SE449996B - (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr - Google Patents

(6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr

Info

Publication number
SE449996B
SE449996B SE8006860A SE8006860A SE449996B SE 449996 B SE449996 B SE 449996B SE 8006860 A SE8006860 A SE 8006860A SE 8006860 A SE8006860 A SE 8006860A SE 449996 B SE449996 B SE 449996B
Authority
SE
Sweden
Prior art keywords
crystalline
bishhydrochloride
pyridiniummethyl
carboxylate
carboxyprop
Prior art date
Application number
SE8006860A
Other languages
English (en)
Swedish (sv)
Other versions
SE8006860L (sv
Inventor
T Miller
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8006860L publication Critical patent/SE8006860L/
Publication of SE449996B publication Critical patent/SE449996B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8006860A 1979-10-02 1980-10-01 (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr SE449996B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934203 1979-10-02

Publications (2)

Publication Number Publication Date
SE8006860L SE8006860L (sv) 1981-04-03
SE449996B true SE449996B (sv) 1987-06-01

Family

ID=10508245

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8006860A SE449996B (sv) 1979-10-02 1980-10-01 (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr

Country Status (14)

Country Link
US (1) US4467086A (ja)
JP (1) JPS5657789A (ja)
AU (1) AU540382B2 (ja)
BE (1) BE885488A (ja)
CH (1) CH644609A5 (ja)
DE (1) DE3037104C2 (ja)
FR (1) FR2466469A1 (ja)
GB (1) GB2064513B (ja)
IE (1) IE50269B1 (ja)
IT (1) IT1128569B (ja)
NL (1) NL8005439A (ja)
NZ (1) NZ195116A (ja)
SE (1) SE449996B (ja)
ZA (1) ZA806082B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963542A (en) * 1976-09-08 1990-10-16 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
US4594417A (en) * 1981-10-30 1986-06-10 Eli Lilly Company Crystalline antibiotic salt
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
AT387022B (de) * 1986-06-04 1988-11-25 Biochemie Gmbh Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines

Also Published As

Publication number Publication date
IT1128569B (it) 1986-05-28
US4467086A (en) 1984-08-21
IE802051L (en) 1981-04-02
FR2466469B1 (ja) 1984-02-10
AU540382B2 (en) 1984-11-15
ZA806082B (en) 1982-05-26
IT8049782A0 (it) 1980-10-01
DE3037104A1 (de) 1981-04-16
GB2064513A (en) 1981-06-17
AU6288080A (en) 1981-04-09
CH644609A5 (de) 1984-08-15
SE8006860L (sv) 1981-04-03
BE885488A (fr) 1981-04-01
JPH0245634B2 (ja) 1990-10-11
GB2064513B (en) 1983-09-14
NL8005439A (nl) 1981-04-06
DE3037104C2 (de) 1986-04-30
IE50269B1 (en) 1986-03-19
JPS5657789A (en) 1981-05-20
FR2466469A1 (fr) 1981-04-10
NZ195116A (en) 1982-09-07

Similar Documents

Publication Publication Date Title
SE449996B (sv) (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr
CS214721B2 (en) Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate
KR0180798B1 (ko) 결정성 페니실린 유도체, 그의 제법 및 용도
US5407929A (en) Triazolylthiomethylthio cephalosporin hydrochhloride, its crystalline hydrate and the production of the same
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
DE3686749T2 (de) Cephalosporinverbindungen und sie enthaltende bakterizide.
CA1339418C (en) Cephalosporin antibiotics
CH651574A5 (de) Cephalosporinantibiotika, ihre herstellung und pharmazeutische zubereitungen.
CN102190656A (zh) 含有五元杂环的噁唑烷酮抗菌素
US4810702A (en) Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient
JP2575590B2 (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
EP0261990B1 (en) Crystalline cephem carboxylic acid addition salt
US4026888A (en) Certain derivatives of particular 3-thiolated cephalosporins
US4061862A (en) Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin
DE2645144A1 (de) Cephalosporinverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
JPH04338392A (ja) 新規セフェム誘導体及びその製造方法
JPH01301683A (ja) 新規セフエム化合物
JPH02270871A (ja) 新規β−ラクタム系抗生物質の一水和物および溶媒和物
JPH03167190A (ja) 新規化合物、その製法及びそれを含む医薬組成物
DE2263439A1 (de) Gegen methicillin-resistente staemme von staphylococcus aureus wirksame antibiotica
NL8103350A (nl) Nieuwe cefalosporineverbindingen met antibiotische activiteit.
JPH02152982A (ja) 新規セファロスポリン化合物及び抗菌剤
JPS6191191A (ja) 抗菌性７β‐複素環式セフエム
GB2045238A (en) Novel cephalosporins

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8006860-4

Effective date: 19940510

Format of ref document f/p: F